Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	protein kinase activity	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 LATS1 MAPK15 TIE1 FGR FYN	2.56e-09	600	106	18	GO:0004672
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 LATS1 MAPK15 TIE1 FGR FYN	3.37e-08	709	106	18	GO:0016773
GeneOntologyMolecularFunction	kinase activity	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 LATS1 MAPK15 TIE1 FGR FYN	1.04e-07	764	106	18	GO:0016301
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 LATS1 MAPK15 TIE1 FGR POLQ FYN	4.52e-07	938	106	19	GO:0016772
GeneOntologyMolecularFunction	protein tyrosine kinase activity	MAP2K4 PDGFRB SRMS TEK PTK6 TIE1 FGR FYN	1.05e-06	145	106	8	GO:0004713
GeneOntologyMolecularFunction	protein serine kinase activity	ROCK2 PRKD2 MAP2K4 PIM2 CDK12 CIT GSK3B PKMYT1 PRKD3 LATS1 MAPK15	3.66e-06	363	106	11	GO:0106310
GeneOntologyMolecularFunction	potassium:chloride symporter activity	SLC12A6 SLC12A4 SLC12A7	1.19e-05	9	106	3	GO:0015379
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	ROCK2 PRKD2 MAP2K4 PIM2 CDK12 CIT GSK3B PKMYT1 PRKD3 LATS1 MAPK15	2.52e-05	446	106	11	GO:0004674
GeneOntologyMolecularFunction	ammonium channel activity	SLC12A6 SLC12A4 SLC12A7	3.09e-05	12	106	3	GO:0008519
GeneOntologyMolecularFunction	histone H3K9 acetyltransferase activity	KAT2A KAT2B	8.35e-05	3	106	2	GO:0043992
GeneOntologyMolecularFunction	non-membrane spanning protein tyrosine kinase activity	SRMS PTK6 FGR FYN	1.03e-04	46	106	4	GO:0004715
GeneOntologyMolecularFunction	tau-protein kinase activity	ROCK2 GSK3B FYN	2.08e-04	22	106	3	GO:0050321
GeneOntologyMolecularFunction	protein kinase binding	SLC12A6 PRKD2 HDAC5 PDGFRB CDK12 APP CIT GSK3B KAT2B LATS1 SLC12A4 NBEAL2 FGR SLC12A7	2.11e-04	873	106	14	GO:0019901
GeneOntologyMolecularFunction	chloride:monoatomic cation symporter activity	SLC12A6 SLC12A4 SLC12A7	2.38e-04	23	106	3	GO:0015377
GeneOntologyMolecularFunction	monoatomic anion:monoatomic cation symporter activity	SLC12A6 SLC12A4 SLC12A7	3.46e-04	26	106	3	GO:0015296
GeneOntologyMolecularFunction	ATP-dependent activity	ABCA3 DDX52 ABCC5 TWNK MCM4 NLRP3 MYO5C UBA7 DDX3Y POLQ CARNS1	4.20e-04	614	106	11	GO:0140657
GeneOntologyMolecularFunction	peptidase activator activity	ROCK2 CASP8 APP NLRP3	5.26e-04	70	106	4	GO:0016504
GeneOntologyMolecularFunction	ATP hydrolysis activity	ABCA3 DDX52 ABCC5 TWNK MCM4 NLRP3 DDX3Y POLQ CARNS1	5.71e-04	441	106	9	GO:0016887
GeneOntologyMolecularFunction	kinase binding	SLC12A6 PRKD2 HDAC5 PDGFRB CDK12 APP CIT GSK3B KAT2B LATS1 SLC12A4 NBEAL2 FGR SLC12A7	6.03e-04	969	106	14	GO:0019900
GeneOntologyMolecularFunction	scaffold protein binding	CASP8 CIT CACNA1G FYN	1.52e-03	93	106	4	GO:0097110
GeneOntologyMolecularFunction	helicase activity	DDX52 TWNK MCM4 DDX3Y POLQ	1.55e-03	158	106	5	GO:0004386
GeneOntologyMolecularFunction	tau protein binding	ROCK2 GSK3B FYN	1.87e-03	46	106	3	GO:0048156
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	SLC12A6 ABCC5 ANO8 SLC12A4 SLC12A7	2.19e-03	171	106	5	GO:0015103
GeneOntologyBiologicalProcess	protein autophosphorylation	PRKD2 PIM2 PDGFRB CDK12 SRMS GSK3B PTK6 MAPK15 FGR FYN	3.36e-07	228	108	10	GO:0046777
GeneOntologyBiologicalProcess	ammonium import across plasma membrane	SLC12A6 SLC12A4 SLC12A7	5.56e-07	4	108	3	GO:0140157
GeneOntologyBiologicalProcess	ammonium transmembrane transport	SLC12A6 SLC12A4 SLC12A7	3.84e-05	13	108	3	GO:0072488
GeneOntologyBiologicalProcess	positive regulation of cytokine production	ROCK2 PRKD2 CASP8 REL KAT2A APP TEK NLRP3 SLC11A1 CD34 TRIM56 FGR	5.76e-05	586	108	12	GO:0001819
GeneOntologyBiologicalProcess	regulation of transferase activity	MAP2K4 PDGFRB CDK12 APP TEK GSK3B PTK6 PKMYT1 KAT2B LATS1 MAPK15 SLC11A1 TIE1 FGR	8.45e-05	810	108	14	GO:0051338
GeneOntologyBiologicalProcess	regulation of anatomical structure size	ROCK2 SLC12A6 ARHGAP32 DUSP5 TTC3 CIT GSK3B KAT2B LATS1 SLC12A4 CACNA1G SLC12A7	9.55e-05	618	108	12	GO:0090066
GeneOntologyBiologicalProcess	regulation of phosphate metabolic process	ROCK2 DDIT4 MAP2K4 ABCA3 PDGFRB CDK12 APP TEK GSK3B PTK6 PKMYT1 KAT2B LATS1 MAPK15 SLC11A1 TIE1 LIMCH1 FGR FYN	1.36e-04	1421	108	19	GO:0019220
GeneOntologyBiologicalProcess	regulation of phosphorus metabolic process	ROCK2 DDIT4 MAP2K4 ABCA3 PDGFRB CDK12 APP TEK GSK3B PTK6 PKMYT1 KAT2B LATS1 MAPK15 SLC11A1 TIE1 LIMCH1 FGR FYN	1.38e-04	1423	108	19	GO:0051174
GeneOntologyBiologicalProcess	neuron migration	DDIT4 ARHGAP32 GSK3B LMX1B FYN PLXNA1 PCM1	1.51e-04	218	108	7	GO:0001764
GeneOntologyBiologicalProcess	positive regulation of phosphate metabolic process	ROCK2 MAP2K4 PDGFRB APP TEK GSK3B PTK6 KAT2B LATS1 MAPK15 SLC11A1 TIE1 LIMCH1 FYN	1.99e-04	879	108	14	GO:0045937
GeneOntologyBiologicalProcess	positive regulation of phosphorus metabolic process	ROCK2 MAP2K4 PDGFRB APP TEK GSK3B PTK6 KAT2B LATS1 MAPK15 SLC11A1 TIE1 LIMCH1 FYN	1.99e-04	879	108	14	GO:0010562
GeneOntologyBiologicalProcess	regulation of phosphorylation	ROCK2 MAP2K4 PDGFRB CDK12 APP TEK GSK3B PTK6 PKMYT1 KAT2B LATS1 MAPK15 SLC11A1 TIE1 LIMCH1 FGR FYN	2.09e-04	1226	108	17	GO:0042325
GeneOntologyBiologicalProcess	positive regulation of phosphorylation	ROCK2 MAP2K4 PDGFRB APP TEK GSK3B PTK6 LATS1 MAPK15 SLC11A1 TIE1 LIMCH1 FYN	2.20e-04	780	108	13	GO:0042327
GeneOntologyBiologicalProcess	anatomical structure formation involved in morphogenesis	ROCK2 SLC12A6 PRKD2 HDAC5 PDGFRB DUSP5 VPS33A CASP8 KLHL41 PDCL2 KAT2A TEK GSK3B LATS1 TIE1 NBEAL2 CD34 TANC1 PLXNA1	2.35e-04	1483	108	19	GO:0048646
GeneOntologyBiologicalProcess	regulation of kinase activity	MAP2K4 PDGFRB CDK12 APP TEK PTK6 PKMYT1 KAT2B LATS1 SLC11A1 TIE1 FGR	2.51e-04	686	108	12	GO:0043549
GeneOntologyBiologicalProcess	regulation of protein phosphorylation	ROCK2 MAP2K4 PDGFRB CDK12 APP TEK GSK3B PTK6 PKMYT1 KAT2B LATS1 MAPK15 SLC11A1 LIMCH1 FGR FYN	2.66e-04	1133	108	16	GO:0001932
GeneOntologyCellularComponent	ruffle	PDGFRB KLHL41 CIT PTK6 SYNJ2 FGR RASGRP2	9.80e-05	206	108	7	GO:0001726
Domain	Protein_kinase_ATP_BS	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 MAPK15 TIE1 FGR FYN	6.02e-11	379	108	17	IPR017441
Domain	PROTEIN_KINASE_ATP	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 LATS1 MAPK15 TIE1 FGR FYN	1.40e-10	459	108	18	PS00107
Domain	Prot_kinase_dom	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 LATS1 MAPK15 TIE1 FGR FYN	3.88e-10	489	108	18	IPR000719
Domain	PROTEIN_KINASE_DOM	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 LATS1 MAPK15 TIE1 FGR FYN	4.42e-10	493	108	18	PS50011
Domain	Kinase-like_dom	ROCK2 PRKD2 MAP2K4 PIM2 PDGFRB CDK12 SRMS TEK CIT GSK3B PTK6 PKMYT1 PRKD3 LATS1 MAPK15 TIE1 FGR FYN	1.99e-09	542	108	18	IPR011009
Domain	KCL_cotranspt	SLC12A6 SLC12A4 SLC12A7	7.49e-07	4	108	3	IPR000076
Domain	Tyr_kinase_cat_dom	PDGFRB SRMS TEK PTK6 TIE1 FGR FYN	7.67e-07	88	108	7	IPR020635
Domain	TyrKc	PDGFRB SRMS TEK PTK6 TIE1 FGR FYN	7.67e-07	88	108	7	SM00219
Domain	S_TKc	ROCK2 PRKD2 MAP2K4 PIM2 CDK12 TEK CIT GSK3B PKMYT1 PRKD3 LATS1 MAPK15	1.13e-06	359	108	12	SM00220
Domain	PROTEIN_KINASE_TYR	PDGFRB SRMS TEK PTK6 TIE1 FGR FYN	1.49e-06	97	108	7	PS00109
Domain	Tyr_kinase_AS	PDGFRB SRMS TEK PTK6 TIE1 FGR FYN	1.49e-06	97	108	7	IPR008266
Domain	SLC12A_fam	SLC12A6 SLC12A4 SLC12A7	6.47e-06	7	108	3	IPR004842
Domain	Ser/Thr_kinase_AS	ROCK2 PRKD2 MAP2K4 PIM2 CDK12 CIT GSK3B PKMYT1 PRKD3 LATS1 MAPK15	7.04e-06	357	108	11	IPR008271
Domain	PROTEIN_KINASE_ST	ROCK2 PRKD2 MAP2K4 PIM2 CDK12 CIT GSK3B PKMYT1 PRKD3 LATS1 MAPK15	8.02e-06	362	108	11	PS00108
Domain	Pkinase_Tyr	PDGFRB SRMS TEK PTK6 TIE1 FGR FYN	9.95e-06	129	108	7	PF07714
Domain	SLC12_C	SLC12A6 SLC12A4 SLC12A7	1.03e-05	8	108	3	IPR018491
Domain	SLC12	SLC12A6 SLC12A4 SLC12A7	1.03e-05	8	108	3	PF03522
Domain	Pkinase	ROCK2 PRKD2 MAP2K4 PIM2 CDK12 CIT GSK3B PKMYT1 PRKD3 LATS1 MAPK15	1.30e-05	381	108	11	PF00069
Domain	Ser-Thr/Tyr_kinase_cat_dom	PDGFRB SRMS TEK PTK6 TIE1 FGR FYN	1.55e-05	138	108	7	IPR001245
Domain	C1_1	ROCK2 PRKD2 CIT PRKD3 RASGRP2	1.94e-05	57	108	5	PF00130
Domain	Hist_acetylase_PCAF	KAT2A KAT2B	3.31e-05	2	108	2	IPR016376
Domain	PCAF_N	KAT2A KAT2B	3.31e-05	2	108	2	IPR009464
Domain	KCC1	SLC12A6 SLC12A4	3.31e-05	2	108	2	IPR000622
Domain	PCAF_N	KAT2A KAT2B	3.31e-05	2	108	2	PF06466
Domain	ZF_DAG_PE_1	ROCK2 PRKD2 CIT PRKD3 RASGRP2	3.42e-05	64	108	5	PS00479
Domain	ZF_DAG_PE_2	ROCK2 PRKD2 CIT PRKD3 RASGRP2	3.42e-05	64	108	5	PS50081
Domain	C1	ROCK2 PRKD2 CIT PRKD3 RASGRP2	3.69e-05	65	108	5	SM00109
Domain	PE/DAG-bd	ROCK2 PRKD2 CIT PRKD3 RASGRP2	3.98e-05	66	108	5	IPR002219
Domain	Protein_Kinase_C_mu-related	PRKD2 PRKD3	9.90e-05	3	108	2	IPR015727
Domain	AA-permease/SLC12A_dom	SLC12A6 SLC12A4 SLC12A7	2.67e-04	22	108	3	IPR004841
Domain	AA_permease	SLC12A6 SLC12A4 SLC12A7	2.67e-04	22	108	3	PF00324
Domain	LRR_6	LRRC45 NLRP3 TONSL NLRP13	2.87e-04	55	108	4	PF13516
Domain	P-loop_NTPase	MAGI1 ABCA3 DDX52 ABCC5 TWNK MCM4 TUFM NLRP3 MYO5C SULT1B1 DDX3Y GTPBP3 POLQ NLRP13	3.76e-04	848	108	14	IPR027417
Domain	PH_dom-like	ROCK2 PRKD2 ACAP1 ARHGAP9 PLEKHN1 CIT WDFY4 PRKD3 NBEAL2	8.20e-04	426	108	9	IPR011993
Domain	PH-BEACH_dom	WDFY4 NBEAL2	9.07e-04	8	108	2	IPR023362
Domain	-	WDFY4 NBEAL2	9.07e-04	8	108	2	2.30.29.40
Domain	PH_BEACH	WDFY4 NBEAL2	9.07e-04	8	108	2	PS51783
Domain	TPR	TTC3 TONSL TTC39A TANC1 GPSM1	9.18e-04	129	108	5	SM00028
Domain	TPR_repeat	TTC3 TONSL TTC39A TANC1 GPSM1	1.05e-03	133	108	5	IPR019734
Domain	BEACH	WDFY4 NBEAL2	1.16e-03	9	108	2	PS50197
Domain	Beach	WDFY4 NBEAL2	1.16e-03	9	108	2	PF02138
Domain	-	WDFY4 NBEAL2	1.16e-03	9	108	2	1.10.1540.10
Domain	Beach	WDFY4 NBEAL2	1.16e-03	9	108	2	SM01026
Domain	BEACH_dom	WDFY4 NBEAL2	1.16e-03	9	108	2	IPR000409
Domain	PH	ROCK2 PRKD2 ACAP1 ARHGAP9 PLEKHN1 CIT PRKD3	1.16e-03	278	108	7	SM00233
Domain	PH_DOMAIN	ROCK2 PRKD2 ACAP1 ARHGAP9 PLEKHN1 CIT PRKD3	1.19e-03	279	108	7	PS50003
Domain	PH_domain	ROCK2 PRKD2 ACAP1 ARHGAP9 PLEKHN1 CIT PRKD3	1.21e-03	280	108	7	IPR001849
Domain	Pkinase_C	ROCK2 CIT LATS1	1.27e-03	37	108	3	IPR017892
Domain	SH3	ARHGAP32 SRMS ARHGAP9 PTK6 FGR FYN	1.60e-03	216	108	6	SM00326
Domain	SH3	ARHGAP32 SRMS ARHGAP9 PTK6 FGR FYN	1.60e-03	216	108	6	PS50002
Domain	SH3_domain	ARHGAP32 SRMS ARHGAP9 PTK6 FGR FYN	1.76e-03	220	108	6	IPR001452
Domain	Pkinase_C	ROCK2 CIT LATS1	1.83e-03	42	108	3	PF00433
Domain	PH	ROCK2 PRKD2 ACAP1 ARHGAP9 CIT PRKD3	2.15e-03	229	108	6	PF00169
Domain	SH3_1	ARHGAP32 ARHGAP9 PTK6 FGR FYN	2.65e-03	164	108	5	PF00018
Domain	TPR_REGION	TTC3 TONSL TTC39A TANC1 GPSM1	2.72e-03	165	108	5	PS50293
Domain	TPR	TTC3 TONSL TTC39A TANC1 GPSM1	2.72e-03	165	108	5	PS50005
Domain	SH2	SRMS PTK6 FGR FYN	2.81e-03	101	108	4	PF00017
Domain	uDENN	DENND5B DENND2B	2.88e-03	14	108	2	SM00800
Domain	uDENN	DENND5B DENND2B	3.31e-03	15	108	2	PF03456
Domain	DENN	DENND5B DENND2B	3.77e-03	16	108	2	SM00799
Domain	DENN	DENND5B DENND2B	3.77e-03	16	108	2	PF02141
Domain	dDENN	DENND5B DENND2B	3.77e-03	16	108	2	PF03455
Domain	UDENN	DENND5B DENND2B	3.77e-03	16	108	2	PS50946
Domain	DDENN	DENND5B DENND2B	3.77e-03	16	108	2	PS50947
Domain	dDENN	DENND5B DENND2B	3.77e-03	16	108	2	SM00801
Domain	dDENN_dom	DENND5B DENND2B	3.77e-03	16	108	2	IPR005112
Domain	uDENN_dom	DENND5B DENND2B	3.77e-03	16	108	2	IPR005113
Domain	DENN	DENND5B DENND2B	3.77e-03	16	108	2	PS50211
Domain	DENN_dom	DENND5B DENND2B	3.77e-03	16	108	2	IPR001194
Domain	SH2	SRMS PTK6 FGR FYN	3.82e-03	110	108	4	SM00252
Domain	-	ABCA3 DDX52 ABCC5 TWNK MCM4 TUFM SULT1B1 DDX3Y GTPBP3 POLQ NLRP13	3.92e-03	746	108	11	3.40.50.300
Domain	SH2	SRMS PTK6 FGR FYN	3.94e-03	111	108	4	PS50001
Domain	SH2	SRMS PTK6 FGR FYN	4.07e-03	112	108	4	IPR000980
Domain	-	SRMS PTK6 FGR FYN	4.07e-03	112	108	4	3.30.505.10
Domain	AGC-kinase_C	ROCK2 CIT LATS1	4.17e-03	56	108	3	IPR000961
Domain	AGC_KINASE_CTER	ROCK2 CIT LATS1	4.17e-03	56	108	3	PS51285
Domain	S_TK_X	ROCK2 CIT LATS1	4.17e-03	56	108	3	SM00133
Pathway	REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS	SLC12A6 SLC12A4 SLC12A7	8.65e-06	7	90	3	M27339
Pathway	REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS	SLC12A6 SLC12A4 SLC12A7	8.65e-06	7	90	3	MM15081
Pathway	REACTOME_CRMPS_IN_SEMA3A_SIGNALING	GSK3B FYN PLXNA1	1.08e-04	15	90	3	MM15031
Pathway	REACTOME_CRMPS_IN_SEMA3A_SIGNALING	GSK3B FYN PLXNA1	1.33e-04	16	90	3	M8245
Pubmed	The protein tyrosine kinase family of the human genome.	PDGFRB SRMS TEK PTK6 TIE1 FGR FYN	8.34e-09	83	109	7	11114734
Pubmed	A dominant negative mutant of the KCC1 K-Cl cotransporter: both N- and C-terminal cytoplasmic domains are required for K-Cl cotransport activity.	SLC12A6 SLC12A4 SLC12A7	2.99e-08	3	109	3	11551954
Pubmed	Insulin-like growth factor 1 stimulates KCl cotransport, which is necessary for invasion and proliferation of cervical cancer and ovarian cancer cells.	SLC12A6 SLC12A4 SLC12A7	2.99e-08	3	109	3	15262997
Pubmed	K-Cl cotransporter gene expression during human and murine erythroid differentiation.	SLC12A6 SLC12A4 SLC12A7	2.99e-08	3	109	3	21733850
Pubmed	Influence of K-Cl cotransporter activity on activation of volume-sensitive Cl- channels in human osteoblasts.	SLC12A6 SLC12A4 SLC12A7	1.20e-07	4	109	3	12637262
Pubmed	Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.	PRKD2 PIM2 PDGFRB PTK6 MAPK15 FBXO10 TIE1 TRIM56 FGR FYN	2.90e-07	372	109	10	22939624
Pubmed	Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation.	TEK TIE1 CD34	5.95e-07	6	109	3	10446940
Pubmed	Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels.	PDGFRB TEK LYVE1 CD34	7.72e-07	23	109	4	29237738
Pubmed	Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation.	TEK LYVE1 CD34	1.04e-06	7	109	3	15705793
Pubmed	Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice.	TEK TIE1 CD34	1.66e-06	8	109	3	15644447
Pubmed	Similar effects of all WNK3 variants on SLC12 cotransporters.	SLC12A6 SLC12A4 SLC12A7	1.66e-06	8	109	3	21613606
Pubmed	Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition.	SLC12A6 SLC12A4 SLC12A7	1.66e-06	8	109	3	11395011
Pubmed	The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters.	SLC12A6 SLC12A4 SLC12A7	1.66e-06	8	109	3	24393035
Pubmed	Cation chloride cotransporters interact with the stress-related kinases Ste20-related proline-alanine-rich kinase (SPAK) and oxidative stress response 1 (OSR1).	SLC12A6 SLC12A4 SLC12A7	1.66e-06	8	109	3	12386165
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ROCK2 MAGI1 ARHGAP32 ABCC5 PLEKHN1 SLITRK2 SLC12A4 NBEAL2 TANC1 SLC12A7 PLXNA1	1.85e-06	569	109	11	30639242
Pubmed	Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development.	TEK TIE1 CD34	2.48e-06	9	109	3	9472016
Pubmed	Cation-chloride cotransporters and neuronal function.	SLC12A6 SLC12A4 SLC12A7	2.48e-06	9	109	3	19323993
Pubmed	Genetic dissection of tie pathway in mouse lymphatic maturation and valve development.	TEK LYVE1 TIE1	2.48e-06	9	109	3	24764452
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	CAPN9 CDK12 SRMS KAT2A GSK3B PTK6 KAT2B SULT1B1 LATS1 FGR FYN PLXNA1	3.27e-06	730	109	12	34857952
Pubmed	The LKLF transcription factor is required for normal tunica media formation and blood vessel stabilization during murine embryogenesis.	TEK TIE1 CD34	3.54e-06	10	109	3	9367982
Pubmed	Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.	TEK TIE1 CD34	3.54e-06	10	109	3	7596435
Pubmed	Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.	PRKD2 CDK12 GSK3B PKMYT1 FYN	4.85e-06	78	109	5	17192257
Pubmed	Cardiac mouse lymphatics: developmental and anatomical update.	TEK LYVE1 CD34	6.45e-06	12	109	3	24700724
Pubmed	Abnormal embryonic lymphatic vessel development in Tie1 hypomorphic mice.	LYVE1 TIE1 CD34	6.45e-06	12	109	3	20223757
Pubmed	Skeletal myogenic progenitors in the endothelium of lung and yolk sac.	TEK TIE1 CD34	8.37e-06	13	109	3	14567980
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PRKD2 CDK12 DUSP5 TWNK KAT2A TTC3 CIT ANO8 PKMYT1 SLC12A4 LMX1B NBEAL2 TANC1 PLXNA1	9.54e-06	1105	109	14	35748872
Pubmed	Transcriptional coactivator p300/CBP-associated factor and p300/CBP-associated factor type B are required for normal estrogen response of the mouse uterus.	KAT2A KAT2B	9.73e-06	2	109	2	15502373
Pubmed	Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters.	SLC12A6 SLC12A4	9.73e-06	2	109	2	34031912
Pubmed	Glycogen synthase kinase-3β (GSK-3β) deficiency inactivates the NLRP3 inflammasome-mediated cell pyroptosis in LPS-treated periodontal ligament cells (PDLCs).	GSK3B NLRP3	9.73e-06	2	109	2	33905062
Pubmed	Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment.	PRKD2 PRKD3	9.73e-06	2	109	2	30841931
Pubmed	Evidence for heterotypic interaction between the receptor tyrosine kinases TIE-1 and TIE-2.	TEK TIE1	9.73e-06	2	109	2	10995770
Pubmed	Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells.	TEK TIE1	9.73e-06	2	109	2	8395828
Pubmed	Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis.	KAT2A KAT2B	9.73e-06	2	109	2	11027331
Pubmed	Localization of the angiopoietin receptors Tie-1 and Tie-2 on the primary cilia in the female reproductive organs.	TEK TIE1	9.73e-06	2	109	2	15893943
Pubmed	SLC12A ion transporter mutations in sporadic and familial human congenital hydrocephalus.	SLC12A6 SLC12A7	9.73e-06	2	109	2	31393094
Pubmed	Acetylation of the influenza A virus polymerase subunit PA in the N-terminal domain positively regulates its endonuclease activity.	KAT2A KAT2B	9.73e-06	2	109	2	34270849
Pubmed	Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis.	CASP8 CD34	9.73e-06	2	109	2	15735742
Pubmed	A yeast genetic assay for caspase cleavage of the amyloid-beta precursor protein.	CASP8 APP	9.73e-06	2	109	2	10911620
Pubmed	Sequence requirements for binding of Src family tyrosine kinases to activated growth factor receptors.	PDGFRB FYN	9.73e-06	2	109	2	7730365
Pubmed	Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival.	TEK TIE1	9.73e-06	2	109	2	17504972
Pubmed	Alzheimer's disease genetic mutation evokes ultrastructural alterations: correlation to an intracellular Abeta deposition and the level of GSK-3beta-P(Y216) phosphorylated form.	APP GSK3B	9.73e-06	2	109	2	19501118
Pubmed	PDGF-induced phosphorylation of Tyr28 in the N-terminus of Fyn affects Fyn activation.	PDGFRB FYN	9.73e-06	2	109	2	9425276
Pubmed	Tie1-Tie2 interactions mediate functional differences between angiopoietin ligands.	TEK TIE1	9.73e-06	2	109	2	20227369
Pubmed	p250GAP, a neural RhoGAP protein, is associated with and phosphorylated by Fyn.	ARHGAP32 FYN	9.73e-06	2	109	2	12788081
Pubmed	Protein kinase D3 conditional knockout impairs osteoclast formation and increases trabecular bone volume in male mice.	PRKD2 PRKD3	9.73e-06	2	109	2	37044359
Pubmed	Amyloid β induces NLRP3 inflammasome activation in retinal pigment epithelial cells via NADPH oxidase- and mitochondria-dependent ROS production.	APP NLRP3	9.73e-06	2	109	2	28004443
Pubmed	Methylglyoxal produced by amyloid-β peptide-induced nitrotyrosination of triosephosphate isomerase triggers neuronal death in Alzheimer's disease.	APP TPI1	9.73e-06	2	109	2	24614897
Pubmed	Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia.	SLC12A6 SLC12A4	9.73e-06	2	109	2	31835175
Pubmed	Nav1.7 is phosphorylated by Fyn tyrosine kinase which modulates channel expression and gating in a cell type-dependent manner.	SCN9A FYN	9.73e-06	2	109	2	29790812
Pubmed	Gcn5 and PCAF negatively regulate interferon-β production through HAT-independent inhibition of TBK1.	KAT2A KAT2B	9.73e-06	2	109	2	25269644
Pubmed	Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.	KAT2A KAT2B	9.73e-06	2	109	2	28678170
Pubmed	Tie-1: A potential target for anti-angiogenesis therapy.	TEK TIE1	9.73e-06	2	109	2	26489611
Pubmed	Protein kinase d isoforms differentially modulate cofilin-driven directed cell migration.	PRKD2 PRKD3	9.73e-06	2	109	2	24840177
Pubmed	Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src.	PDGFRB FYN	9.73e-06	2	109	2	7687537
Pubmed	NLRP3 Inflammasome Priming in the Retina of Diabetic Mice Requires REDD1-Dependent Activation of GSK3β.	DDIT4 GSK3B	9.73e-06	2	109	2	38546584
Pubmed	Platelet-derived growth factor receptor sequences important for binding of src family tyrosine kinases.	PDGFRB FYN	9.73e-06	2	109	2	1661130
Pubmed	Divergent functions of histone acetyltransferases KAT2A and KAT2B in keratinocyte self-renewal and differentiation.	KAT2A KAT2B	9.73e-06	2	109	2	37259855
Pubmed	Influenza A virus nucleoprotein is acetylated by histone acetyltransferases PCAF and GCN5.	KAT2A KAT2B	9.73e-06	2	109	2	29555684
Pubmed	Glycogen synthase kinase 3 inhibition promotes lysosomal biogenesis and autophagic degradation of the amyloid-β precursor protein.	APP GSK3B	9.73e-06	2	109	2	22927642
Pubmed	The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells.	TEK TIE1	9.73e-06	2	109	2	8846781
Pubmed	A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains.	TEK TIE1	9.73e-06	2	109	2	1312667
Pubmed	Association between the PDGF receptor and members of the src family of tyrosine kinases.	PDGFRB FYN	9.73e-06	2	109	2	1696179
Pubmed	T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice.	APP CACNA1G	9.73e-06	2	109	2	30571684
Pubmed	Opposing growth regulatory roles of protein kinase D isoforms in human keratinocytes.	PRKD2 PRKD3	9.73e-06	2	109	2	25802335
Pubmed	Disruption of erythroid K-Cl cotransporters alters erythrocyte volume and partially rescues erythrocyte dehydration in SAD mice.	SLC12A6 SLC12A4	9.73e-06	2	109	2	17510708
Pubmed	Beta-amyloid protein (25-35) disrupts hippocampal network activity: role of Fyn-kinase.	APP FYN	9.73e-06	2	109	2	19294646
Pubmed	Protein kinases D2 and D3 are novel growth regulators in HCC1806 triple-negative breast cancer cells.	PRKD2 PRKD3	9.73e-06	2	109	2	23393329
Pubmed	Cloning and characterization of KCC3 and KCC4, new members of the cation-chloride cotransporter gene family.	SLC12A6 SLC12A7	9.73e-06	2	109	2	10347194
Pubmed	Identification of a novel cDNA clone encoding protein tyrosine kinase in murine skin.	SRMS PTK6	9.73e-06	2	109	2	7962951
Pubmed	Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis.	TEK TIE1	9.73e-06	2	109	2	14530387
Pubmed	Tie2 receptor expression and phosphorylation in cultured cells and mouse tissues.	TEK TIE1	9.73e-06	2	109	2	9108247
Pubmed	The SRC-family tyrosine kinase HCK shapes the landscape of SKAP2 interactome.	SRMS FGR FYN	1.06e-05	14	109	3	29568343
Pubmed	Tie1 is required for lymphatic valve and collecting vessel development.	TEK LYVE1 TIE1	1.06e-05	14	109	3	25576926
Pubmed	Angiopoietin-1 is required for Schlemm's canal development in mice and humans.	TEK LYVE1 CD34	1.06e-05	14	109	3	29106382
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ROCK2 SLC12A6 ARMC3 DDX52 ABCC5 TWNK REL KAT2A SRBD1 TTC3 TUFM LATS1 SLC12A4 SCN9A LIMCH1 POLQ	1.10e-05	1442	109	16	35575683
Pubmed	Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation.	TEK TIE1 CD34	1.33e-05	15	109	3	11032855
Pubmed	Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.	PDGFRB TEK LYVE1	1.33e-05	15	109	3	21606590
Pubmed	JunB is essential for mammalian placentation.	TEK TIE1 CD34	1.33e-05	15	109	3	10022836
Pubmed	Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1.	PDGFRB TEK LYVE1 TIE1	1.60e-05	48	109	4	28924218
Pubmed	Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10.	HDAC5 TEK TIE1	1.63e-05	16	109	3	16873063
Pubmed	Polydom Is an Extracellular Matrix Protein Involved in Lymphatic Vessel Remodeling.	TEK LYVE1 TIE1	1.63e-05	16	109	3	28179430
Pubmed	Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation.	PDGFRB TEK FYN	1.63e-05	16	109	3	10022833
Pubmed	Genetic variants in apoptosis and immunoregulation-related genes are associated with risk of chronic lymphocytic leukemia.	CAPN9 CYP2B6 PDGFRB CASP8 MCM4 NLRP13	2.23e-05	179	109	6	19074885
Pubmed	Expanding the substantial interactome of NEMO using protein microarrays.	PIM2 PSMA3 TEK PRKD3 FGR	2.49e-05	109	109	5	20098747
Pubmed	The complex PrP(c)-Fyn couples human oligomeric Aβ with pathological tau changes in Alzheimer's disease.	APP FYN	2.91e-05	3	109	2	23175838
Pubmed	Protein kinase D-HDAC5 signaling regulates erythropoiesis and contributes to erythropoietin cross-talk with GATA1.	HDAC5 PRKD3	2.91e-05	3	109	2	22983445
Pubmed	Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.	PRKD2 PRKD3	2.91e-05	3	109	2	26253275
Pubmed	Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization.	PDGFRB TEK	2.91e-05	3	109	2	19801450
Pubmed	Phosphorylation of FE65 at threonine 579 by GSK3β stimulates amyloid precursor protein processing.	APP GSK3B	2.91e-05	3	109	2	28963516
Pubmed	Prolyl isomerase Pin1 promotes amyloid precursor protein (APP) turnover by inhibiting glycogen synthase kinase-3β (GSK3β) activity: novel mechanism for Pin1 to protect against Alzheimer disease.	APP GSK3B	2.91e-05	3	109	2	22184106
Pubmed	Role of the caspase-8/RIPK3 axis in Alzheimer's disease pathogenesis and Aβ-induced NLRP3 inflammasome activation.	CASP8 NLRP3	2.91e-05	3	109	2	36602874
Pubmed	Tie1 regulates the Tie2 agonistic role of angiopoietin-2 in human lymphatic endothelial cells.	TEK TIE1	2.91e-05	3	109	2	22342979
Pubmed	Fyn-dependent phosphorylation of PlexinA1 and PlexinA2 at conserved tyrosines is essential for zebrafish eye development.	FYN PLXNA1	2.91e-05	3	109	2	29091353
Pubmed	A Novel Conserved Domain Mediates Dimerization of Protein Kinase D (PKD) Isoforms: DIMERIZATION IS ESSENTIAL FOR PKD-DEPENDENT REGULATION OF SECRETION AND INNATE IMMUNITY.	PRKD2 PRKD3	2.91e-05	3	109	2	27662904
Pubmed	HDAC5 RNA interference ameliorates acute renal injury by upregulating KLF2 and inhibiting NALP3 expression in a mouse model of oxalate nephropathy.	HDAC5 NLRP3	2.91e-05	3	109	2	36183679
Pubmed	Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases.	SRMS PTK6	2.91e-05	3	109	2	12725532
Pubmed	Tat acetyl-acceptor lysines are important for human immunodeficiency virus type-1 replication.	KAT2A KAT2B	2.91e-05	3	109	2	11956210
Pubmed	Genetic variants in fas signaling pathway genes and risk of gastric cancer.	MAP2K4 CASP8	2.91e-05	3	109	2	23921907
Pubmed	Pterostilbene inhibits amyloid-β-induced neuroinflammation in a microglia cell line by inactivating the NLRP3/caspase-1 inflammasome pathway.	APP NLRP3	2.91e-05	3	109	2	29737568
Pubmed	Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems.	TEK TIE1	2.91e-05	3	109	2	27941161
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	ROCK2 PRKD2 ACAP1 ARHGAP9 PLEKHN1 PRKD3	3.95e-04	206	84	6	682
GeneFamily	WD repeat domain containing\|BEACH domain containing	WDFY4 NBEAL2	7.52e-04	9	84	2	1230
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	PDGFRB TEK TIE1	8.44e-04	40	84	3	321
GeneFamily	SH2 domain containing	SRMS PTK6 FGR FYN	1.26e-03	101	84	4	741
GeneFamily	ATAC complex	KAT2A KAT2B	1.61e-03	13	84	2	1058
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TTC3 TTC39A TANC1 GPSM1	2.03e-03	115	84	4	769
GeneFamily	Lysine acetyltransferases\|ATAC complex\|SAGA complex\|GCN5 related N-acetyltransferases	KAT2A KAT2B	2.77e-03	17	84	2	1059
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	KAT2A KAT2B	2.77e-03	17	84	2	486
GeneFamily	GCN5 related N-acetyltransferases	KAT2A KAT2B	5.51e-03	24	84	2	1134
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND5B DENND2B	5.97e-03	25	84	2	504
GeneFamily	NLR family	NLRP3 NLRP13	5.97e-03	25	84	2	666
GeneFamily	Pyrin domain containing\|Pyrin and HIN domain family	NLRP3 NLRP13	5.97e-03	25	84	2	994
Coexpression	GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP	DDIT4 ACAP1 ABCC5 KAT2A TTC3 UBA7 DDX3Y SLC12A7	1.83e-06	200	108	8	M3035
Coexpression	AIZARANI_LIVER_C20_LSECS_3	ROCK2 DUSP5 APP PRKD3 LYVE1 TIE1 DDX3Y TANC1 LIMCH1	3.79e-06	295	108	9	M39121
Coexpression	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN	PDGFRB TEK TIE1 FGR	8.97e-06	32	108	4	MM17
Coexpression	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN	PDGFRB TEK TIE1 FGR	1.15e-05	34	108	4	M45005
Coexpression	VALK_AML_CLUSTER_11	APP MYO5C CD34 FYN	1.81e-05	38	108	4	M9334
Coexpression	GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	SLC12A6 PRKD2 MAP2K4 CDK12 GSK3B NLRP3 SULT1B1	1.91e-05	199	108	7	M5526
Coexpression	GSE17580_TREG_VS_TEFF_DN	APP HEXD PRKD3 CD34 TANC1 SLC12A7 RASGRP2	1.97e-05	200	108	7	M3671
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP	HDAC5 RNF149 CASP8 PTK6 KAT2B DDX3Y CWF19L1	1.97e-05	200	108	7	M3842
Coexpression	CHEN_METABOLIC_SYNDROM_NETWORK	ARMC3 PDGFRB DUSP5 RNF149 ABCC5 ARHGAP9 PLEKHN1 ARMC2 WDFY4 PKMYT1 UBA7 SLC11A1 CD34 CD37 TONSL TANC1	4.89e-05	1242	108	16	M1920
Coexpression	SWEET_LUNG_CANCER_KRAS_DN	CYP2B6 PDGFRB CYP2S1 TEK DENND2B LYVE1 TIE1 LIMCH1 FYN	6.40e-05	422	108	9	M7396
Coexpression	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	ABCC5 APP LYVE1 SLC12A4 TANC1 RASGRP2	7.07e-05	168	108	6	M1275
Coexpression	SWEET_LUNG_CANCER_KRAS_DN	CYP2B6 PDGFRB CYP2S1 TEK DENND2B LYVE1 TIE1 LIMCH1 FYN	9.43e-05	444	108	9	MM1051
Coexpression	CHEN_METABOLIC_SYNDROM_NETWORK	ARMC3 PDGFRB DUSP5 RNF149 ABCC5 ARHGAP9 PLEKHN1 ARMC2 WDFY4 PKMYT1 UBA7 SLC11A1 CD34 CD37 TONSL TANC1	9.65e-05	1316	108	16	MM1052
Coexpression	SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	ABCC5 APP LYVE1 SLC12A4 TANC1 RASGRP2	1.00e-04	179	108	6	MM534
Coexpression	DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_DENDRITIC_CELLS	RNF149 NLRP3 SLC11A1 CD37 FGR	1.21e-04	116	108	5	M39286
Coexpression	GARY_CD5_TARGETS_UP	DDIT4 PIM2 DUSP5 TTC3 GSK3B NBEAL2 CD37 FGR FYN	1.52e-04	473	108	9	M17693
Coexpression	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	SIGLEC12 PIM2 TWNK MCM4 NLRP3 PKMYT1 PLXNA1 RASGRP2	1.54e-04	371	108	8	M2132
Coexpression	MULLIGHAN_MLL_SIGNATURE_2_DN	APP TTC3 MYO5C SLC12A4 TIE1 CD34 GTPBP3	1.60e-04	279	108	7	M16867
Coexpression	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP	ABCC5 DAO APP DENND2B TANC1 SLC12A7	1.74e-04	198	108	6	M3596
Coexpression	GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP	ABCC5 DAO APP DENND2B TANC1 SLC12A7	1.74e-04	198	108	6	M3601
Coexpression	GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN	KLHL41 APP DENND2B MYO5C LMX1B FBXO41	1.74e-04	198	108	6	M5571
Coexpression	GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	SLC12A6 DUSP5 ARHGAP9 TTC3 PRKD3 NBEAL2	1.84e-04	200	108	6	M293
Coexpression	GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP	CAPN9 ALG11 TWNK SLC11A1 TANC1 SLC12A7	1.84e-04	200	108	6	M9380
Coexpression	GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP	PRKD2 ABCC5 APP TTC3 SLC12A7 PCM1	1.84e-04	200	108	6	M5819
Coexpression	GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP	ABCA3 RNF149 APP TTC3 CD34 FYN	1.84e-04	200	108	6	M4545
Coexpression	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN	PRKD2 CYP2B6 SRMS CYP2S1 TEK SCN9A	1.84e-04	200	108	6	M9637
Coexpression	GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP	DDIT4 ACAP1 CIT UBA7 CD37 RASGRP2	1.84e-04	200	108	6	M8328
Coexpression	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN	ACAP1 PRKD3 KAT2B CD37 TANC1 CARNS1	1.84e-04	200	108	6	M9765
Coexpression	GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN	PRKD2 DDIT4 PDGFRB ABCC5 CYP2S1 RASGRP2	1.84e-04	200	108	6	M8504
Coexpression	GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN	ABCA3 LRRC45 SRBD1 CIT UBA7 TRIM56	1.84e-04	200	108	6	M6208
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN	ACAP1 ARMC3 ARHGAP9 CYP2S1 CARNS1 RASGRP2	1.84e-04	200	108	6	M7432
Coexpression	GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP	DDIT4 CDK12 DUSP5 REL PDCL2 NLRP3	1.84e-04	200	108	6	M7764
Coexpression	GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN	ACAP1 ARMC3 PSMA3 DUSP5 ABCC5 FYN	1.84e-04	200	108	6	M6650
Coexpression	GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN	ACAP1 ABCA3 DUSP5 CASP8 TRIM56 CARNS1	1.84e-04	200	108	6	M7833
Coexpression	GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN	SULT1B1 SLC12A4 CD34 SLC12A7 FYN RASGRP2	1.84e-04	200	108	6	M9071
Coexpression	GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN	KAT2A PRKD3 NBEAL2 POLQ SLC12A7 RASGRP2	1.84e-04	200	108	6	M5560
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	SLC12A6 DUSP5 TTC3 PRKD3 METTL13 RASGRP2	1.84e-04	200	108	6	M9188
Coexpression	GSE7460_TCONV_VS_TREG_THYMUS_UP	ACAP1 CST9L CYP2S1 TRIM56 TANC1 SLC12A7	1.84e-04	200	108	6	M5675
Coexpression	KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP	PRKD2 DDIT4 ABCC5 APP TTC3 SLC12A7	1.84e-04	200	108	6	M3012
Coexpression	GSE7460_TCONV_VS_TREG_LN_UP	PIM2 CYP2S1 APP PTK6 SLC12A7 RASGRP2	1.84e-04	200	108	6	M5673
Coexpression	GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP	PRKD2 DDIT4 TTC3 DDX3Y SLC12A7 RASGRP2	1.84e-04	200	108	6	M3038
Coexpression	GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN	PDGFRB CIT PKMYT1 SLITRK2 MAPK15 TONSL	1.84e-04	200	108	6	M6959
Coexpression	GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN	TWNK DENND2B PRKD3 SLC12A7 RASGRP2	1.85e-04	127	108	5	M2915
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	DDIT4 ARHGAP32 APP TEK TTC3 MYO5C TIE1 NBEAL2 CD34 LIMCH1 FYN	1.94e-04	721	108	11	M1999
Coexpression	LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN	DENND5B PRKD2 ACAP1 TEK WDFY4 LYVE1 TIE1 PLXNA1 RASGRP2	2.00e-04	491	108	9	MM455
Coexpression	DESCARTES_ORGANOGENESIS_WHITE_BLOOD_CELLS	ACAP1 VPS33A CASP8 ARHGAP9 REL WDFY4 NLRP3 LYVE1 SLC11A1 CD37	2.32e-04	615	108	10	MM3641
Coexpression	AIZARANI_LIVER_C9_LSECS_1	DUSP5 APP PRKD3 LYVE1 TIE1 TANC1 LIMCH1	2.70e-04	304	108	7	M39113
Coexpression	MEL18_DN.V1_UP	DDIT4 ABCC5 TEK TIE1 PLXNA1	3.00e-04	141	108	5	M2784
Coexpression	HAN_SATB1_TARGETS_UP	DENND5B DDIT4 PTK6 LATS1 FBXO10 CD34 LIMCH1 FYN	3.83e-04	425	108	8	M9639
Coexpression	BENPORATH_MYC_TARGETS_WITH_EBOX	PIM2 PSMA3 CASP8 MCM4 APP GSK3B	3.88e-04	230	108	6	M27
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE	SIGLEC12 SLC12A6 MAP2K4 HDAC5 RNF149 ARHGAP9 SLC11A1 TPI1	3.89e-04	426	108	8	M41019
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	PRKD2 DDIT4 ACAP1 PIM2 RNF149 CASP8 ARHGAP9 PRKD3 KAT2B LATS1 NBEAL2 CD37 DDX3Y FYN PCM1 RASGRP2	3.99e-04	1492	108	16	M40023
Coexpression	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS	CYP2B6 DDX52 CST9L TEK PTK6 SLC12A4 TIE1 NBEAL2 CD34 CACNA1G GPSM1	4.05e-04	786	108	11	M2388
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3	PRKD2 DDIT4 PIM2 PDGFRB ARHGAP9 NBEAL2 TANC1 SLC12A7 FYN RASGRP2	2.17e-05	382	106	10	GSM476684_500
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_1000	PRKD2 CDK12 VPS33A CASP8 ARHGAP9 TEK WDFY4 LYVE1 SLC11A1 TIE1 NBEAL2 CD34 LIMCH1 RASGRP2	2.67e-05	764	106	14	DevelopingKidney_e15.5_Endothelial cells_emap-29977_1000
ToppCell	3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-Activated_T\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 PIM2 ARHGAP9 CD37 FBXO41 FGR RASGRP2	3.45e-07	183	109	7	2e36bbc241682e47e880be21c1503abd7d0c3082
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Myeloid-LYVE1+_Macrophage\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TWNK CYP2S1 NLRP3 SLC11A1 SCN9A FGR CHRNA10	4.29e-07	189	109	7	9e3c083174a64ea78648c6d48498fc4e721b569f
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic-Myeloid\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TWNK CYP2S1 NLRP3 SLC11A1 SCN9A FGR CHRNA10	4.29e-07	189	109	7	6e19bfa52406ebe095daa99f958ec4d596ce6e39
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	DUSP5 APP TEK TIE1 CD34 LIMCH1 FYN	4.77e-07	192	109	7	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DDIT4 ACAP1 CASP8 ARHGAP9 FGR FYN RASGRP2	4.94e-07	193	109	7	db9378c5bb5c27b321957a05dcabf40e97a3b725
ToppCell	COVID-19-kidney-FLT1+PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	DDIT4 DUSP5 APP TEK LYVE1 TIE1 FYN	4.94e-07	193	109	7	479abb1cd2eb978b8a4fdb900069a6329fc8cade
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 ARHGAP9 CD37 FYN	5.11e-07	194	109	7	1bb5ac162f547de9dd91680df247b49a00920062
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 ARHGAP9 CD37 FYN	5.11e-07	194	109	7	2e614d86c366a022929ae307f170db8b142c386a
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 ARHGAP9 CD37 FYN	5.11e-07	194	109	7	7937f2d1113bd85fee0df95fab74b0e022cdebce
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 ARHGAP9 CD37 FYN	5.48e-07	196	109	7	a2607e972ff11d2e2fb8359e39605c236c0a1c63
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 ARHGAP9 CD37 FYN	5.48e-07	196	109	7	2fd2784c61f6dd17405f14ec2fd5d9a09e65a230
ToppCell	proximal-Hematologic-Natural_Killer\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DDIT4 ACAP1 CASP8 ARHGAP9 CD37 FGR FYN	6.06e-07	199	109	7	b7463dffca8b2a7f053bfecdabcb8429989cbc0f
ToppCell	proximal-3-Hematologic-Natural_Killer\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DDIT4 ACAP1 CASP8 ARHGAP9 CD37 FGR FYN	6.06e-07	199	109	7	bbaf31cf35d1706c421bef54fe2f809fa6590a72
ToppCell	ILEUM-inflamed-(7)_Endothelial_cell\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MAGI1 APP TEK LYVE1 TIE1 CD34 LIMCH1	6.06e-07	199	109	7	97052c28e354833901f28d339b09f97f50a5b752
ToppCell	5'-GW_trimst-2-LymphNode\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 PIM2 ARHGAP9 REL CD37 DDX3Y RASGRP2	6.06e-07	199	109	7	4a9ca133125dc25a06e7b1cfea15ecffa449c20e
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 PIM2 ARHGAP9 REL CD37 DDX3Y RASGRP2	6.06e-07	199	109	7	45d0d275ffb4183e3e71f4701e121ef9853ebd10
ToppCell	proximal-Hematologic-Natural_Killer-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	DDIT4 ACAP1 CASP8 ARHGAP9 CD37 FGR FYN	6.06e-07	199	109	7	e523ae54f34612c94cf7677309c11d351747bdf4
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 PIM2 ARHGAP9 REL CD37 DDX3Y RASGRP2	6.06e-07	199	109	7	da20998253ad08a4a127a98b991b26237edb61a2
ToppCell	facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP5 RNF149 REL KLHL41 SLC11A1 FGR	2.38e-06	156	109	6	3f0b9e35d4da85c90759b930052e5b9c3cde9b15
ToppCell	facs-Lung-nan-3m-Myeloid-intermediate_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DUSP5 RNF149 REL KLHL41 SLC11A1 FGR	2.38e-06	156	109	6	69e6e8810d1738a66c9821910f41498931cf30cc
ToppCell	facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DUSP5 RNF149 REL KLHL41 SLC11A1 FGR	2.56e-06	158	109	6	b35bab2b93d0af821bfae18a358eb7dddaf3860f
ToppCell	facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DUSP5 RNF149 REL KLHL41 SLC11A1 FGR	2.56e-06	158	109	6	7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SRMS TEK UBA7 TIE1 CD34 SLC12A7	2.76e-06	160	109	6	04714d0b9bad4c11fa193ed168e2d84a4df39e2e
ToppCell	facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DDIT4 DUSP5 RNF149 REL SLC11A1 FGR	3.07e-06	163	109	6	bbbc3f0ce2616d07136f69ce682ba1d3790711d9
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D3\|343B / Donor, Lineage, Cell class and subclass (all cells)	DDIT4 ACAP1 ARHGAP9 PLEKHN1 FBXO41 FYN	3.07e-06	163	109	6	8a4931c9fdaedcf6c319157821d3556cd25fc9e5
ToppCell	facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DDIT4 DUSP5 RNF149 REL SLC11A1 FGR	3.18e-06	164	109	6	11dfd84f5fb90de330858e1e852848832734e004
ToppCell	Thalamus-Hematopoietic\|Thalamus / BrainAtlas - Mouse McCarroll V32	ARHGAP9 WDFY4 NLRP3 LYVE1 SLC11A1 CD37	3.41e-06	166	109	6	76d60ac7ac5d1eaf530f0c741d9c48e0bd58396b
ToppCell	facs-Heart-LV-24m-Lymphocytic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 PIM2 ARMC3 DUSP5 WDFY4 CD37	3.53e-06	167	109	6	4a669eafde3582a451614ad304769b47aa1d9578
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARMC3 SLC11A1 DDX3Y FGR CARNS1 FYN	3.65e-06	168	109	6	f45dbcd7753117a3e41e1412bce2100d52fa7fd0
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Lymphocytic\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 DUSP5 REL CYP2S1 CD37 SLC12A7	3.65e-06	168	109	6	dc1143bd8db70c490167d73a525fd9b783eba960
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Lymphocytic-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 DUSP5 REL CYP2S1 CD37 SLC12A7	3.65e-06	168	109	6	a75d63ae8ad64b5560853775f6df398feb314ce8
ToppCell	facs-Heart-LV-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 PIM2 ARMC3 DUSP5 WDFY4 CD37	3.78e-06	169	109	6	ae85cef7ef8f761c19f4af2a23fe333641c38a92
ToppCell	facs-Heart-LV-24m-Lymphocytic-B_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACAP1 PIM2 ARMC3 DUSP5 WDFY4 CD37	3.78e-06	169	109	6	c01bc3f2f299109086ded83dc11e98559bf1940c
ToppCell	5'-Adult-Distal_Rectal-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TWNK NLRP3 SLC11A1 SCN9A FGR CHRNA10	4.32e-06	173	109	6	b335ca2a247156eba821943b2b9fc9922230b409
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLC12A6 ACAP1 ARHGAP9 ARMC2 FGR FYN	4.77e-06	176	109	6	dbc4f64cd39b229f2355ca1d0215cc7f6a767dce
ToppCell	Bronchial_Biopsy-Immune-Neutrophils\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	ARHGAP9 NLRP3 SLC11A1 CD37 FGR RASGRP2	5.26e-06	179	109	6	8c50e13927c09de05c86cd90dd6f71cee004b0d3
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP32 DUSP5 PLEKHN1 PTK6 MYO5C TANC1	5.26e-06	179	109	6	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	COVID-19-Heart-EC_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAGI1 TEK SULT1B1 TIE1 SYNJ2 CD34	5.26e-06	179	109	6	2a53d94f6c30bf887dfe88f1693ea057218c852d
ToppCell	droplet-Marrow-BM-1m-Hematologic-hematopoietic_precursor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDIT4 PDGFRB KAT2A TTC3 CD34 FYN	5.43e-06	180	109	6	ff34195bb7325e61fbf823c103c5e6115d8f1248
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-endo_arterial_(9)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	TEK SULT1B1 TIE1 SYNJ2 CD34 FGR	5.43e-06	180	109	6	5861b44acfb8fe92c281c8355bf19c059b3dcd64
ToppCell	367C-Myeloid-Dendritic-cDC1\|367C / Donor, Lineage, Cell class and subclass (all cells)	PIM2 DUSP5 CYP2S1 WDFY4 NLRP3 SCN9A	5.78e-06	182	109	6	6f5228ac47f9ab46d165740cf2655b5ba217acbe
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB SYNJ2 LMX1B TANC1 GPSM1 FYN	5.97e-06	183	109	6	3c516fe5083f02bad1f464ed284010b4131a833c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB SYNJ2 LMX1B TANC1 GPSM1 FYN	5.97e-06	183	109	6	9c2689d76fc6d30f5ab093428aa669d0a98953cf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRB SYNJ2 LMX1B TANC1 GPSM1 FYN	6.16e-06	184	109	6	7294b379ce4cb8fa75e432559082f93cd106aaf5
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DENND5B ACAP1 PIM2 REL CD37 DDX3Y	6.35e-06	185	109	6	e913c64f9b4873443d88dce270f0b7b6d1b4cbce
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-Treg\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SLC12A6 ACAP1 PIM2 CASP8 KAT2B FYN	6.35e-06	185	109	6	a86a3a1a187a4d8d7762bc6d3dcb22c982178d22
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DUSP5 TEK SULT1B1 TIE1 SYNJ2 CD34	6.35e-06	185	109	6	a7ae76058b2082020cadec49d63b9f4e24d21734
ToppCell	3'-Adult-LargeIntestine-Hematopoietic-T_cells-NK_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 ARHGAP9 PLEKHN1 FGR FYN RASGRP2	6.55e-06	186	109	6	e083356f72995645f873ca0157d56bea5e942044
ToppCell	PCW_05-06-Endothelial-Endothelial_mature-endo_bronchial_(8)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	DUSP5 CYP2S1 LYVE1 TIE1 CD34 RASGRP2	6.55e-06	186	109	6	0cc7504297fd0c97ea50e4b3ff58fcedc4c1cfaa
ToppCell	tumor_Lung-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	DDIT4 PIM2 DUSP5 APP SCN9A TTC39A	6.55e-06	186	109	6	3d7c1a281fb82db4471283f39937007d889a5f38
ToppCell	(1)_B_cells\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ACAP1 PIM2 ARHGAP9 WDFY4 CD37 RASGRP2	6.55e-06	186	109	6	fe0f8e99ca766e004c351835fdbc2dc888dceb62
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ACAP1 PIM2 ARHGAP9 REL CD37 RASGRP2	6.55e-06	186	109	6	3941d4af5f2b209d71f59d7d920f2322131b4a0c
ToppCell	367C-Myeloid-Dendritic-cDC1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	ACAP1 PIM2 DUSP5 WDFY4 NBEAL2 SCN9A	6.75e-06	187	109	6	3748203b62abf51b74dfcfc4f18b3ba831b63a96
ToppCell	(1)_B_CD27pos\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ACAP1 PIM2 REL WDFY4 CD37 RASGRP2	6.75e-06	187	109	6	bb189942123eb03dd6505f1af8771dd7285bb8b9
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	CAPN9 MAGI1 MYO5C NBEAL2 TANC1 LIMCH1	6.75e-06	187	109	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TEK TIE1 SYNJ2 CD34 FGR FYN	6.96e-06	188	109	6	c2c51c6526defe2600302901159b8abbb58d7595
ToppCell	NS-moderate-d_07-13-Lymphoid-B_cell\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DENND5B ACAP1 ARHGAP9 WDFY4 CD37 RASGRP2	6.96e-06	188	109	6	e9ed34cfea1d93eaa8e63d5b5dbb64f1520d9c4c
ToppCell	Smart-seq2-spleen_(Smart-seq2)\|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	DENND5B DDIT4 ACAP1 PIM2 REL CD37	7.18e-06	189	109	6	b0244a9d1b5c8ad4708750b691184f3491b13900
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_artery\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DUSP5 TEK SULT1B1 TIE1 SYNJ2 CD34	7.40e-06	190	109	6	f6c38d197fd9d69a4f97cb2e72cd4747984c1a86
ToppCell	LV-08._Macrophage\|World / Chamber and Cluster_Paper	RNF149 WDFY4 LYVE1 SLC11A1 SCN9A FGR	7.62e-06	191	109	6	e7a0bc46ba9ba772636a583f3387748418e18832
ToppCell	(0)_T_CD4\|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1)	ACAP1 PIM2 ARHGAP9 CD37 FYN RASGRP2	7.62e-06	191	109	6	ba289658777a2669fda9da9128e87adb60fd8430
ToppCell	COVID-19-kidney-Stressed_EC\|kidney / Disease (COVID-19 only), tissue and cell type	DDIT4 DUSP5 TEK LYVE1 TIE1 FYN	7.62e-06	191	109	6	d35aa842b813ea0eff7362abc894cca4e86b2fb2
ToppCell	Adult-Epithelial\|Adult / Lineage, Cell type, age group and donor	MAGI1 ABCA3 DENND2B MYO5C TANC1 LIMCH1	7.85e-06	192	109	6	efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCell	URO\|World / Disease, Lineage and Cell Type	SIGLEC12 RNF149 SULT1B1 SLC11A1 NBEAL2 FGR	8.09e-06	193	109	6	421dc0996c6c973f88e90197b651255ae4dd13a2
ToppCell	COVID-19-Endothelial_cells-Inflamed_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	MAGI1 DUSP5 TEK TIE1 CD34 TANC1	8.09e-06	193	109	6	979ebefa527f86bebeea5d94e626ee6c1cc7d53b
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 CD37 FYN	8.09e-06	193	109	6	7022b3ce6220d6d1722a4e2947630a8da002cdce
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 CD37 FYN	8.09e-06	193	109	6	3083305b7ae09a37d7f45b915d49b2b396276822
ToppCell	3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 CD37 FYN	8.09e-06	193	109	6	1218e74ee5e00d230222b10acc50cb96201016b4
ToppCell	facs-Liver-Non-hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APP TEK LYVE1 TIE1 TANC1 FYN	8.09e-06	193	109	6	8084fa0ce61f1f4a728423b6b81df04eaa5af5b6
ToppCell	NS-moderate-d_07-13-Lymphoid-Treg\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ACAP1 PIM2 CASP8 ARHGAP9 CD37 FYN	8.09e-06	193	109	6	6115d43017070a78d335687bd039c08f00f77029
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 TEK TIE1 CD34 SCN9A TANC1	8.33e-06	194	109	6	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-NK_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 PIM2 ARHGAP9 CD37 FGR FYN	8.33e-06	194	109	6	3fe32e38c95135d152acb1624fec1623339e144a
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MAGI1 TEK TIE1 CD34 SCN9A TANC1	8.33e-06	194	109	6	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	facs-Heart-LA-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B MAGI1 PRKD2 TEK TIE1 LIMCH1	8.33e-06	194	109	6	33cc4f1d716cb71d54cdedbe9bbdc0d7b17c4777
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RNF149 REL NLRP3 SLC11A1 DDX3Y FGR	8.33e-06	194	109	6	dfe0ece81922bfd7c6673726d3ea2365cbdb5513
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	DUSP5 TEK LYVE1 TIE1 CD34 FYN	8.58e-06	195	109	6	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	3'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ACAP1 PIM2 DUSP5 ARHGAP9 CD37 FYN	8.58e-06	195	109	6	38ed4f48d450119cd50d6b85bd2d966a39d02c6b
ToppCell	356C\|World / Donor, Lineage, Cell class and subclass (all cells)	PIM2 ARHGAP9 REL NLRP3 FGR RASGRP2	8.58e-06	195	109	6	b19609f519188cf27859cbdc014e65fc38e24391
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 ARHGAP9 CD37 FYN	8.58e-06	195	109	6	fc7a1091c42f09c7630b41f65a704a5350ff7437
ToppCell	COPD-Lymphoid-T\|COPD / Disease state, Lineage and Cell class	ACAP1 PIM2 CASP8 KAT2B SYNJ2 FYN	8.83e-06	196	109	6	30e53b8050d2a041f855d0e39bbd8f923c64c489
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid-Microglia\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	CASP8 ARHGAP9 WDFY4 NLRP3 SLC12A4 CD37	8.83e-06	196	109	6	89a0ccd0684777927d99d5fc5b7c498f3f124250
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	DUSP5 APP TEK LYVE1 TIE1 CD34	8.83e-06	196	109	6	7cbb19108b4553ef60ef5c230a29de1662c02efe
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW08-Myeloid\|GW08 / Sample Type, Dataset, Time_group, and Cell type.	CASP8 ARHGAP9 WDFY4 NLRP3 SLC12A4 CD37	8.83e-06	196	109	6	91a8c4798572d6c1f03cef5e8e5464ed0046c7cf
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Endothelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAGI1 TEK MYO5C LYVE1 TIE1 CD34	8.83e-06	196	109	6	629236f95c838a473b5964a49b7c1b7ad863ea12
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	REL WDFY4 NLRP3 LYVE1 SLC11A1 FGR	9.09e-06	197	109	6	6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	RNF149 REL NLRP3 SLC11A1 CD37 FGR	9.09e-06	197	109	6	e27577a1fa553986044512f52c252a587f864510
ToppCell	medial-Hematologic-Interstitial_Macrophage-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TMEM121B CYP2S1 NLRP3 SLC11A1 CACNA1G FGR	9.09e-06	197	109	6	b90c8a41e99c87b46be699d03cd49c97a2ad51af
ToppCell	3'-Child09-12-SmallIntestine-Endothelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APP TEK LYVE1 TIE1 CD34 LIMCH1	9.09e-06	197	109	6	86a02fd7b4762b3278e5e60b5483b5fc1206e597
ToppCell	medial-Hematologic-Interstitial_Macrophage\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TMEM121B CYP2S1 NLRP3 SLC11A1 CACNA1G FGR	9.09e-06	197	109	6	13aec816e21754eac590a12c3a9c795c41108277
ToppCell	medial-2-Hematologic-Interstitial_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TMEM121B CYP2S1 NLRP3 SLC11A1 CACNA1G FGR	9.09e-06	197	109	6	38a74eeb2a4c8d6a86b133f02f4e6c641f16a3ac
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-NK-ILC-T_NK-ILC\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	DDIT4 ACAP1 ARHGAP9 PLEKHN1 CHRNA10 CARNS1	9.09e-06	197	109	6	cd9172af705f9589890252ab5e8b333ed754bea4
ToppCell	Severe_COVID-19-T/NK-CD4+_T_2\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DDIT4 ACAP1 PIM2 ARHGAP9 PRDX2 FYN	9.36e-06	198	109	6	c8c9343c19198b6534f8f07e74405e29b3a164bf
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDIT4 ACAP1 PIM2 PRDX2 CD37 FYN	9.36e-06	198	109	6	fc8099bce80d84b29bdcc87064d4d8375dddfa0f
ToppCell	Bronchus_Control_(B.)-Immune-TX-B_cells\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ACAP1 PIM2 ARHGAP9 REL CD37 RASGRP2	9.36e-06	198	109	6	6231c44a909dd06f85c8210814e976a5f29148d0
ToppCell	tumor_Lung-Endothelial_cells-Tumor_ECs\|tumor_Lung / Location, Cell class and cell subclass	MAGI1 APP TEK LYVE1 TIE1 CD34	9.36e-06	198	109	6	5228c4bf2513186140c2c4eaa67a268c732bdc84
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 CD37 FYN	9.36e-06	198	109	6	cd1cd0ac2a66578aa38a139322295170002ec049
ToppCell	3'-Pediatric_IBD-SmallIntestine-Endothelial\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APP TEK LYVE1 TIE1 CD34 LIMCH1	9.36e-06	198	109	6	13203249e5743ba2699871c184d141207e550a86
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-MAIT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	ACAP1 PIM2 DUSP5 CD37 POLQ FYN	9.36e-06	198	109	6	f26150ae3fee6b2df2a51efaefbcfeb27f725a65
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DDIT4 ACAP1 PIM2 CASP8 CD37 FYN	9.36e-06	198	109	6	a17eb0e19e04e9d4fe14e19452d79c3c4559817a
ToppCell	3'-Child04-06-SmallIntestine-Endothelial\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APP TEK LYVE1 TIE1 CD34 LIMCH1	9.36e-06	198	109	6	bf4e086c3fc924e999b6eaca87d2beee9b9526c2
Drug	AC1L1J0H	PRKD2 MAP2K4 SRMS APP PRKD3 SULT1B1 CD37 TONSL FGR FYN	3.47e-08	197	108	10	CID000004813
Drug	AC1L1JM9	ROCK2 PRKD2 MAP2K4 PDGFRB CASP8 KAT2A GSK3B PRKD3 MAPK15 TONSL FYN	2.19e-07	304	108	11	CID000005103
Drug	anacardic acid	HDAC5 KAT2A PRDX2 KAT2B CACNA1G	2.84e-07	30	108	5	CID000167551
Drug	NSC618487	ROCK2 SLC12A6 PRKD2 MAP2K4 PIM2 PDGFRB SRMS CASP8 APP TEK GSK3B PRKD3 MAPK15 SLC12A4 TONSL FGR SLC12A7 FYN	3.88e-07	933	108	18	CID000005279
Drug	N-methyl-DL-aspartic acid	MAGI1 PRKD2 ARHGAP32 CASP8 DAO APP CIT PRKD3 MAPK15 TONSL SCN9A CACNA1G TANC1 CHRNA10 FYN	4.81e-07	655	108	15	CID000004376
Drug	NSC611747	ROCK2 SLC12A6 PRKD2 MAP2K4 HDAC5 CASP8 GSK3B MYO5C PRKD3 SLC12A4 SLC12A7	9.35e-07	352	108	11	CID000002534
Drug	imatinib	ROCK2 MAP2K4 PDGFRB SRMS CASP8 TEK CIT PKMYT1 TIE1 CD34 FGR FYN	9.61e-07	430	108	12	CID000005291
Drug	mancozeb	DDIT4 CASP8 PRDX2 TEK GSK3B TPI1	1.01e-06	70	108	6	ctd:C013099
Drug	AC1L1IHP	ROCK2 PRKD2 MAP2K4 CYP2B6 PDGFRB PSMA3 REL APP GSK3B PRKD3 LATS1 MAPK15 SLC12A4 TONSL SLC12A7	1.80e-06	728	108	15	CID000004584
Drug	Potassium Chloride	SLC12A6 SLC12A4 SLC12A7	2.05e-06	6	108	3	DB00761
Drug	ZD4190	PDGFRB TEK TIE1 PLXNA1	2.19e-06	20	108	4	CID005329032
Drug	LY294002	ROCK2 PRKD2 DDIT4 MAP2K4 PDGFRB SRMS CASP8 REL TEK GSK3B PRKD3 LYVE1 MAPK15 TONSL FYN	2.50e-06	748	108	15	CID000003973
Drug	AC1L9DEH	PRKD2 MAP2K4 CYP2B6 PDGFRB CASP8 REL KAT2A APP GSK3B PRKD3 KAT2B MAPK15 TONSL	3.05e-06	569	108	13	CID000442783
Drug	4-epidoxorubicin	ROCK2 PRKD2 MAP2K4 PSMA3 ABCC5 CASP8 TWNK REL PRDX2 GSK3B PRKD3 KAT2B TONSL POLQ PLXNA1	4.71e-06	788	108	15	CID000001690
Drug	5140203; Up 200; 15uM; MCF7; HT_HG-U133A_EA	ROCK2 MAGI1 VPS33A CASP8 MCM4 PRDX2 APP SNAPC3	4.75e-06	198	108	8	908_UP
Drug	Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A	DENND5B CYP2B6 DAO LATS1 SYNJ2 LMX1B SCN9A FYN	5.12e-06	200	108	8	6450_UP
Drug	isocycloheximide	ROCK2 SLC12A6 PRKD2 MAP2K4 CYP2B6 PDGFRB ABCC5 CASP8 REL GSK3B PKMYT1 PRKD3 MAPK15 SLC12A4 CD37 TONSL	5.63e-06	905	108	16	CID000002900
Drug	wartmannin	ROCK2 PRKD2 MAP2K4 PDGFRB SRMS CASP8 REL TEK GSK3B MYO5C PRKD3 LYVE1 MAPK15 TONSL FYN	6.66e-06	811	108	15	CID000005691
Drug	Ditiocarb	DDIT4 CASP8 PRDX2 APP NLRP3	8.21e-06	58	108	5	ctd:D004050
Drug	BiM4	ROCK2 PRKD2 MAP2K4 CASP8 APP GSK3B PRKD3 MAPK15 TONSL	8.33e-06	283	108	9	CID000002399
Drug	SP600125	ROCK2 PRKD2 DDIT4 MAP2K4 PIM2 CASP8 GSK3B PRKD3 MAPK15 TONSL	8.87e-06	362	108	10	CID000008515
Drug	nickel	SRMS PDCL2 APP CIT TUFM UBA7 SLC11A1 TONSL CACNA1G GTPBP3 POLQ TATDN1	1.23e-05	552	108	12	CID000000934
Drug	Furosemide	SLC12A6 PDGFRB CASP8 TEK SLC12A4 TIE1 SLC12A7	1.34e-05	164	108	7	ctd:D005665
Drug	taxol	PRKD2 MAP2K4 CYP2B6 PDGFRB ABCC5 CASP8 TWNK REL CIT PRKD3 UBA7 TONSL	1.42e-05	560	108	12	CID000004666
Drug	4-hydroxynonenal	PRKD2 MAP2K4 PDGFRB PSMA3 CASP8 REL APP GSK3B PRKD3 SLC12A4 TONSL	1.50e-05	471	108	11	CID000001693
Drug	diphenyleneiodonium	ROCK2 PRKD2 MAP2K4 PDGFRB CASP8 PRKD3 MAPK15 TONSL	1.51e-05	232	108	8	CID000003101
Drug	Azitidin	PRKD2 ABCC5 TWNK CIT PRKD3 TONSL POLQ	1.63e-05	169	108	7	CID000005726
Drug	ponatinib	PDGFRB TEK PTK6 FGR FYN	1.80e-05	68	108	5	ctd:C545373
Drug	Acetylcysteine	DDIT4 MAP2K4 PIM2 PDGFRB SRMS CASP8 REL APP GSK3B NLRP3 PTK6 UBA7 CACNA1G FYN	1.94e-05	780	108	14	ctd:D000111
Drug	toluene	PRKD2 SRBD1 APP PRKD3 UBA7 SCN9A CHRNA10	2.04e-05	175	108	7	CID000001140
Drug	((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy)acetic acid	SLC12A4 SLC12A7	2.23e-05	2	108	2	ctd:C095651
Drug	PDBu	ROCK2 PRKD2 MAP2K4 APP GSK3B PRKD3 MAPK15 RASGRP2	2.51e-05	249	108	8	CID000037783
Drug	PKC412	PRKD2 MAP2K4 PDGFRB GSK3B PRKD3	2.72e-05	74	108	5	CID009829523
Drug	phorbol acetate myristate	ROCK2 PRKD2 MAP2K4 PDGFRB SRMS CASP8 REL APP GSK3B PRKD3 KAT2B MAPK15 TIE1 TONSL CACNA1G FGR POLQ FYN RASGRP2	2.96e-05	1399	108	19	CID000004792
Drug	myo-inositol	PRKD2 MAP2K4 PDGFRB SRMS GSK3B PRKD3 KAT2B LATS1 MAPK15 SYNJ2 CACNA1G CHRNA10 FYN TPI1	2.97e-05	811	108	14	CID000000892
Drug	thioridazine hydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	MAGI1 DDIT4 DUSP5 SULT1B1 SYNJ2 SCN9A PCM1	3.23e-05	188	108	7	5921_UP
Drug	2-propylpentanoic acid; Up 200; 200uM; MCF7; HT_HG-U133A_EA	ROCK2 SLC12A6 APP PRKD3 FBXO41 LIMCH1 SNAPC3	3.57e-05	191	108	7	994_UP
Drug	D 2163	PDGFRB TEK TIE1	3.64e-05	14	108	3	CID000148203
Drug	3-(3-chloro-4-hydroxyphenylamino)-4-(4-nitrophenyl)-1H-pyrrole-2,5-dione	CASP8 APP GSK3B	3.64e-05	14	108	3	ctd:C417520
Drug	Dimethisoquin hydrochloride [2773-92-4]; Up 200; 13uM; MCF7; HT_HG-U133A	DDIT4 UBA7 SLC12A4 CD34 FBXO41 LIMCH1 CHRNA10	3.70e-05	192	108	7	2807_UP
Drug	Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; HL60; HT_HG-U133A	MCM4 KAT2A PRDX2 SRBD1 MYO5C SNAPC3 CWF19L1	3.82e-05	193	108	7	1268_DN
Drug	AC1L1D59	PRKD2 MAP2K4 ABCC5 CASP8 GSK3B PRKD3 MAPK15 TONSL	4.01e-05	266	108	8	CID000002199
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HT_HG-U133A	PRDX2 SULT1B1 SLC11A1 SYNJ2 PLXNA1 PCM1 RASGRP2	4.08e-05	195	108	7	2208_DN
Drug	AC1L1G9T	ROCK2 PRKD2 MAP2K4 PDGFRB SRMS PRKD3 MAPK15 TONSL FGR FYN	4.11e-05	433	108	10	CID000003591
Drug	SB202190	ROCK2 MAP2K4 CASP8 GSK3B MAPK15 TONSL	4.35e-05	134	108	6	CID005353940
Drug	Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; MCF7; HT_HG-U133A	ROCK2 MAGI1 PRKD2 PIM2 PRDX2 LIMCH1 PCM1	4.35e-05	197	108	7	3549_DN
Drug	Altretamine [654-05-6]; Down 200; 19uM; HL60; HT_HG-U133A	DENND5B VPS33A PRDX2 SYNJ2 CD37 CHRNA10 PLXNA1	4.35e-05	197	108	7	3090_DN
Drug	Rauwolscine hydrochloride [6211-32-1]; Up 200; 10.2uM; MCF7; HT_HG-U133A	HDAC5 APP PTK6 KAT2B SULT1B1 SLC11A1 SNAPC3	4.35e-05	197	108	7	6274_UP
Drug	Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; MCF7; HT_HG-U133A	DENND5B SLC12A6 PIM2 UBA7 LATS1 SYNJ2 FBXO41	4.35e-05	197	108	7	2751_UP
Drug	Beta-sistosterol [83-46-5]; Down 200; 9.6uM; HL60; HT_HG-U133A	ROCK2 ABCC5 APP NLRP3 CD37 SNAPC3 PLXNA1	4.35e-05	197	108	7	2912_DN
Drug	Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; HL60; HT_HG-U133A	SULT1B1 SLC11A1 SYNJ2 FBXO41 SNAPC3 PLXNA1 RASGRP2	4.35e-05	197	108	7	2131_DN
Drug	(-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; HL60; HG-U133A	PIM2 MCM4 KAT2A APP METTL13 PCM1 RASGRP2	4.35e-05	197	108	7	1780_DN
Drug	acrolein	CYP2B6 PDGFRB CASP8 APP TUFM UBA7	4.72e-05	136	108	6	CID000007847
Drug	1,4-benzothiazine	CYP2B6 CASP8 ARHGAP9	5.56e-05	16	108	3	CID003088997
Drug	Bumetanide	SLC12A6 SLC12A4 SLC12A7	5.56e-05	16	108	3	ctd:D002034
Drug	Calpain inhibitor I	CAPN9 HDAC5 PSMA3 ABCC5 CASP8 APP UBA7 TONSL	5.76e-05	280	108	8	CID000004332
Drug	Streptozocin	DDIT4 MAP2K4 ABCC5 CASP8 DAO ARHGAP9 REL PRDX2 APP TEK GSK3B NLRP3 RASGRP2	6.08e-05	756	108	13	ctd:D013311
Drug	AG213	PRKD2 TUFM PRKD3 FGR FYN	6.62e-05	89	108	5	CID005328803
Drug	AQ4N	CYP2B6 CYP2S1	6.67e-05	3	108	2	ctd:C094428
Drug	cyproconazole	PIM2 SRBD1 DENND2B LYVE1	6.70e-05	46	108	4	CID000086132
Drug	Pkcs	ROCK2 PRKD2 MAP2K4 HDAC5 PRKD3 MAPK15 TONSL	6.71e-05	211	108	7	CID000164073
Drug	Dethiocoenzyme A	CASP8 KAT2A KAT2B MAPK15 TONSL TPI1	7.28e-05	147	108	6	CID000003002
Drug	SB203580	ROCK2 PRKD2 MAP2K4 PDGFRB SRMS CASP8 REL TUFM GSK3B PTK6 PRKD3 MAPK15 TONSL	7.42e-05	771	108	13	CID000176155
Drug	lead compounds	PRKD2 PRKD3 SULT1B1 SLC11A1 TONSL CACNA1G	8.14e-05	150	108	6	CID000073212
Drug	2-naphthol	CYP2B6 ARHGAP9 CYP2S1 DENND2B SULT1B1	8.16e-05	93	108	5	CID000008663
Drug	silver nitrate	ARHGAP32 PDCL2 APP UBA7	8.61e-05	49	108	4	CID000024470
Drug	Methamphetamine	MAGI1 PRKD2 DDIT4 DDX52 DUSP5 ARHGAP9 KAT2A PRDX2 PLEKHN1 TUFM TIE1 SYNJ2 TTC39A CARNS1 GPSM1 FYN RASGRP2 TPI1	1.00e-04	1401	108	18	ctd:D008694
Drug	oleoyl-lysophosphatidic acid	ROCK2 PRKD2 MAP2K4 PDGFRB SRMS GSK3B PRKD3 MAPK15 TONSL	1.04e-04	391	108	9	CID000003987
Drug	lead chromate	PRKD2 PRKD3 SULT1B1 SLC11A1 TONSL	1.05e-04	98	108	5	CID000024460
Drug	cumene hydroperoxide	CYP2B6 PDGFRB CYP2S1 PRDX2	1.09e-04	52	108	4	ctd:C007164
Drug	vandetanib	PDGFRB TEK PTK6 FGR FYN	1.10e-04	99	108	5	CID003081361
Drug	8-bromoguanosine 3',5'-cyclic monophosphate	ROCK2 SLC12A6 PRKD2 MAP2K4 PRKD3 SLC12A4 CACNA1G SLC12A7	1.12e-04	308	108	8	CID000001915
Drug	NSC750927	PDGFRB RNF149 CASP8 UBA7 SLITRK2 TONSL POLQ	1.21e-04	232	108	7	CID000003461
Drug	nsc25485	SLC12A6 PRKD2 SRMS PRKD3 MAPK15 TONSL SCN9A FYN	1.22e-04	312	108	8	CID000004605
Drug	(3Z)-3-[3-(hydroxyamino)indolin-2-ylidene]oxindole	ROCK2 CASP8 GSK3B	1.30e-04	21	108	3	CID016073041
Drug	Sodium Fluoride	ROCK2 DENND5B PRKD2 CASP8 ALG11 DENND2B TUFM GSK3B PTK6 TIE1 FGR GTPBP3 GPSM1 TPI1	1.33e-04	933	108	14	ctd:D012969
Drug	nickel chloride	CAPN9 DDIT4 MAP2K4 DUSP5 CASP8 MCM4 PRDX2 CIT GSK3B NLRP3 KAT2B SULT1B1 SLC12A4 FGR CWF19L1 TPI1	1.36e-04	1178	108	16	ctd:C022838
Drug	1pzj	DDX52 REL PTK6 MAPK15 TONSL PCM1	1.47e-04	167	108	6	CID000447976
Drug	trans-3,4,5-trihydroxystilbene	PDGFRB SRMS CASP8 CYP2S1 APP GSK3B KAT2B SULT1B1 MAPK15 TONSL FYN	1.49e-04	608	108	11	CID000005056
Drug	Potassium	SLC12A6 APP GSK3B NLRP3 SLC12A4	1.52e-04	106	108	5	ctd:D011188
Drug	ruboxistaurin	PRKD2 MAP2K4 PIM2 PDGFRB PRKD3	1.58e-04	107	108	5	CID000153999
Drug	P-38	ROCK2 PRKD2 MAP2K4 SRMS CASP8 REL GSK3B PRKD3 MAPK15 TONSL PCM1	1.60e-04	613	108	11	CID000200878
Drug	hypericin	PRKD2 CASP8 PRKD3 MAPK15 FGR	1.65e-04	108	108	5	CID005281051
Drug	PCB 153	CYP2B6 SRMS UBA7 SCN9A	1.67e-04	58	108	4	CID000037034
Drug	lavendustin A	PRKD2 MAP2K4 SRMS PRKD3 CACNA1G FYN	1.67e-04	171	108	6	CID000003894
Drug	AC1L4NFY	PRKD2 PRKD3 CD34	1.72e-04	23	108	3	CID000160335
Drug	E-PEG	MAP2K4 ABCA3 HDAC5 VPS33A ABCC5 CASP8 KAT2A KAT2B CD34 TONSL PLXNA1	1.79e-04	621	108	11	CID000003310
Drug	17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A	PRKD2 DDIT4 PIM2 ABCC5 APP SLC12A7	1.84e-04	174	108	6	5215_UP
Drug	Betamethasone-d5	PRKD2 DDIT4 CYP2B6 ABCA3 PDGFRB CASP8 REL CYP2S1 SRBD1 APP GSK3B PRKD3 SULT1B1 MAPK15 TONSL SCN9A CHRNA10	1.86e-04	1340	108	17	CID000003003
Drug	Nicorette	ROCK2 PRKD2 CYP2B6 CYP2S1 APP PRKD3 MAPK15 TONSL SCN9A CHRNA10	2.13e-04	529	108	10	CID000000942
Drug	Trichlormethiazide	SLC12A4 SLC12A7	2.21e-04	5	108	2	ctd:D014237
Drug	threohydrobupropion	CYP2B6 APP	2.21e-04	5	108	2	CID000000445
Drug	AC1L1JYL	ROCK2 PRKD2 MAP2K4 PDGFRB SRMS CASP8 PRKD3 MAPK15 FYN	2.26e-04	434	108	9	CID000005262
Drug	AC1OAGFB	ROCK2 PRKD2 ACAP1 PDGFRB PRDX2 PRKD3 SYNJ2 SCN9A RASGRP2 TPI1	2.47e-04	539	108	10	CID006857345
Drug	methoxyethane	MAP2K4 DAO LATS1	2.49e-04	26	108	3	CID000010903
Drug	phorbol 12-myristate	MAGI1 PRKD2 REL PRKD3 MAPK15 TONSL SCN9A	2.50e-04	261	108	7	CID000107854
Drug	tautomycin	ROCK2 PRKD2 MAP2K4 GSK3B PRKD3	2.50e-04	118	108	5	CID000440646
Drug	apocynin	ROCK2 PRKD2 PDGFRB PRKD3 MAPK15 TONSL	2.63e-04	186	108	6	CID000002214
Drug	ethoxytriethyleneglycol	PRKD2 DENND2B PRKD3 LYVE1	2.75e-04	66	108	4	CID000008190
Drug	genistein; Down 200; 10uM; HL60; HT_HG-U133A	ACAP1 HDAC5 TWNK PRDX2 FBXO41 RASGRP2	2.79e-04	188	108	6	1176_DN
Disease	kidney disease (implicated_via_orthology)	KAT2A KAT2B FGR FYN	1.49e-05	41	107	4	DOID:557 (implicated_via_orthology)
Disease	Food Allergy	NLRP3 SLC11A1	3.90e-05	3	107	2	C0016470
Disease	diabetic encephalopathy (biomarker_via_orthology)	APP GSK3B	1.94e-04	6	107	2	DOID:0050850 (biomarker_via_orthology)
Disease	epilepsy (implicated_via_orthology)	SLC12A6 CIT SLC12A4 SCN9A SLC12A7	3.27e-04	163	107	5	DOID:1826 (implicated_via_orthology)
Disease	Bipolar Disorder	SLC12A6 MAGI1 HDAC5 CASP8 DAO APP GSK3B FYN	3.55e-04	477	107	8	C0005586
Disease	heart disease (implicated_via_orthology)	KAT2A GSK3B KAT2B	3.57e-04	38	107	3	DOID:114 (implicated_via_orthology)
Disease	cancer (implicated_via_orthology)	ACAP1 LATS1 FGR GPSM1 FYN TPI1	4.46e-04	268	107	6	DOID:162 (implicated_via_orthology)
Disease	Liver carcinoma	CYP2B6 CASP8 PRDX2 PKMYT1 LYVE1 CD34 TONSL TATDN1	5.30e-04	507	107	8	C2239176
Disease	depressive disorder (biomarker_via_orthology)	CYP2B6 HDAC5 GSK3B	9.00e-04	52	107	3	DOID:1596 (biomarker_via_orthology)
Disease	Metastatic melanoma	ROCK2 MAP2K4 FYN	1.01e-03	54	107	3	C0278883
Disease	Asbestosis	PRDX2 NLRP3	1.15e-03	14	107	2	C0003949
Disease	Pulmonary Fibrosis - from Asbestos Exposure	PRDX2 NLRP3	1.15e-03	14	107	2	C2930617
Disease	carcinoma (implicated_via_orthology)	LATS1 FGR FYN	1.64e-03	64	107	3	DOID:305 (implicated_via_orthology)
Disease	MAJOR AFFECTIVE DISORDER 2	MAGI1 DAO	1.71e-03	17	107	2	C1839839
Disease	Esophageal Neoplasms	CASP8 PRDX2 TUFM	2.90e-03	78	107	3	C0014859
Disease	nicotine dependence	CYP2B6 SULT1B1 TANC1	2.90e-03	78	107	3	EFO_0003768
Disease	Malignant neoplasm of esophagus	CASP8 PRDX2 TUFM	2.90e-03	78	107	3	C0546837
Disease	schizophrenia (is_implicated_in)	DAO GSK3B FYN	2.90e-03	78	107	3	DOID:5419 (is_implicated_in)
Disease	Ovarian Serous Adenocarcinoma	MAP2K4 TEK	3.14e-03	23	107	2	C1335177

Protein segments in the cluster

Peptide	Gene	Start	Entry
ECLGAEGRLALKLFR	CHRNA10	21	Q9GZZ6
SLKLVLIGGCRNKDD	ALG11	336	Q2TAA5
LICTALLARGIDFKG	DDX52	466	Q9Y2R4
KKRGGILCIDSFDIV	BBS7	236	Q8IWZ6
KRCVDKFDIIGIIGE	CDK12	721	Q9NYV4
LGKRICLGEGIARAE	CYP2B6	431	P20813
LLPCGIDKFRGVEFV	APP	171	P05067
EGGGIKKLVDCLRDL	ARMC2	756	Q8NEN0
GLLEALRKELAAVCG	GTPBP3	406	Q969Y2
LIRKCLFRDGKGGVF	FBXO10	431	Q9UK96
LAELVRARGLKLDGC	CARNS1	456	A5YM72
GCGLLDGVFNVELKL	CARNS1	666	A5YM72
RLSLAVQKGECFGLL	ABCA3	1401	Q99758
ACLFLKRGADLGARD	ACAP1	656	Q15027
LFKALADRIGIGCSL	ARMC3	801	Q5W041
RLGCFGLFSKVLDEV	DENND2B	801	P78524
LLCGQKERLKFEGLC	CIT	341	O14578
GLLDCGLRLKKVSFA	ANO8	606	Q9HCE9
LLDRSGNIKLCDFGI	MAP2K4	236	P45985
LALIKDGRVIGGICF	KAT2A	551	Q92830
GCALEAAKLFGRILE	DAO	321	P14920
GRGKFRAEINILLCG	MCM4	496	P33991
EAKEACRLLGLSLAG	LYVE1	56	Q9Y5Y7
GKLKVGDRILAVNGC	MAGI1	1051	Q96QZ7
GERLACKIADFGLAR	FGR	391	P09769
CKIADFGLARLIKDD	FGR	396	P09769
LLRGCIEAFDDSGKV	RASGRP2	16	Q7LDG7
LALIKDGRVIGGICF	KAT2B	546	Q92831
LGIGAFGEVCLARKV	LATS1	711	O95835
LTFEVKIGGCRAELA	DEFB107A	46	Q8IZN7
LALEGERLCKAGDFK	GPSM1	31	Q86YR5
VKLCDFGLARSLGDL	MAPK15	151	Q8TD08
EGFLFVVGCERGKIL	ARNTL2	191	Q8WYA1
LRLLACGDVEGKFDI	CWF19L1	6	Q69YN2
GKRVCLGEGLAKAEL	CYP2S1	436	Q96SQ9
AGRKLKDCGEDLLVE	PCM1	1661	Q15154
FIGIIECGGINLKLE	PDCL2	176	Q8N4E4
GICQFLRLDDLFKLG	PLXNA1	136	Q9UIW2
CLQLLLRGGFDEDVK	HEXD	321	Q8WVB3
SARCLFGLGEVDDKI	KLHL41	386	O60662
VKLCDFGFARIIGEK	PRKD2	691	Q9BZL6
VKLCDFGFARIIGEK	PRKD3	716	O94806
GLCANTVLRFLDLKG	LRRC45	81	Q96CN5
ARLGVVTGKDLGEVC	SLC11A1	111	P49279
RGILKKGDECELLGH	TUFM	281	P49411
LRGLKLLEAKCQGDG	TWNK	216	Q96RR1
KEVAILCSFLLGLGD	MFSD11	351	O43934
QRGILKERVFGCDLG	ARHGAP32	361	A7KAX9
RAEDFRKLGCEVLGV	PRDX2	61	P32119
CKVGDFGLARLIKED	PTK6	326	Q13882
FRLVELSGGCIKIDG	ABCC5	1241	O15440
LEGRAGALCAIKSFV	HEATR5A	606	Q86XA9
DGDGDRKKCLALVSL	CACNA1G	1011	O43497
GLRGALLDVCVEQGK	DDIT4	141	Q9NX09
GLICKIADFGLARLI	FYN	401	P06241
LVGVEEGFLARCVKG	POLQ	686	O75417
KDLGICVLVLGIGDV	COL6A5	1131	A8TX70
LKLCDFGSAKQLVRG	GSK3B	196	P49841
KDGKFQILVCLGTRD	DENND5B	1201	Q6ZUT9
ECRLRLEKGFILDGV	C17orf98	6	A8MV24
ILGEGKLDILKRVCA	CASP8	151	Q14790
RGCLEAGLESLLKAA	FBXO41	641	Q8TF61
LFCKVRLLDGGDFVS	FAM102A	31	Q5T9C2
GCLLELAFKVAAGEL	HDAC5	806	Q9UQL6
LLLGRTRCGKFEDDI	CST9L	91	Q9H4G1
RGKIGLDFCKYLVLD	DDX3Y	331	O15523
VCRDLGLKDSVLAGL	METTL13	616	Q8N6R0
EKALKRGSLLGCFID	CAPN9	221	O14815
VLFGACIEGVVLRDK	SLC12A6	536	Q9UHW9
VLFGACIEGVVLRDK	SLC12A7	471	Q9Y666
CIEGVVLRDKFGEAL	SLC12A7	476	Q9Y666
IDFIDCVREKGGKVL	DUSP5	246	Q16690
EFKKDRGEGLARVLC	CD34	201	P28906
IALLGCVGALKELRC	CD37	71	P11049
DKDFRTGLENGILLC	LIMCH1	41	Q9UPQ0
IAGLDNIILFLRGCK	LIMCH1	76	Q9UPQ0
LRGCKELGLKESQLF	LIMCH1	86	Q9UPQ0
EGKLVKICDFGLARD	PDGFRB	836	P09619
GDFGIRLLCVGLKHL	NLRP3	811	Q96P20
KRDILVAFKGGCSIL	PSAPL1	416	Q6NUJ1
KVVAIGECGLDFDRL	TATDN1	106	Q6P1N9
ELDGLCFKGELPLRA	PLEKHN1	256	Q494U1
LKNLFFLGCRGLEAL	TMEM121B	501	Q9BXQ6
KLTDAYGCLGELRLK	SYNJ2	56	O15056
IDLRRGCAKLIDFGS	PIM2	171	Q9P1W9
RLIHLFCAVLAGGKE	NBEAL2	201	Q6ZNJ1
ESLVKILARGFCVGE	SCN9A	166	Q15858
GEILKFLGREAICPD	SLITRK2	566	Q9H156
AAGRGKLEVCELLLG	TANC1	1086	Q9C0D5
RAVCGLDKLKCLEDG	SNAPC3	101	Q92966
GLACKVADFGLARLL	SRMS	361	Q9H3Y6
LLCGRVGAKEQKDYL	SIGLEC12	11	Q96PQ1
ILNDGDIEKCKRGFI	SULT1B1	61	O43704
CGQGFREAEKIKTLL	SRBD1	571	Q8N5C6
VLFGACIEGVVLRDK	SLC12A4	471	Q9UP95
LEGIKCGLSEKRLDL	CLHC1	371	Q8NHS4
ALVARGGCTFKDKVL	RNF149	111	Q8NC42
LLVGAGAIGCELLKV	UBA7	436	P41226
GAIGCELLKVFALVG	UBA7	441	P41226
RCKLGDFGLLVELGT	PKMYT1	246	Q99640
HRDFAGELEVLCKLG	TIE1	881	P35590
RLGDKCVAELVAALG	TONSL	1081	Q96HA7
GLFEKLAEDLCLLGC	WDFY4	706	Q6ZS81
GLGVIACIGEKLDER	TPI1	121	P60174
FLIGGLLRIGCKIEN	TTC3	146	P53804
GRICGLEEDLKNGKI	ROCK2	646	O75116
LCIAAVDKRGLDVDG	ARHGAP9	561	Q9BRR9
RCKDGVVFGVEKLVL	PSMA3	41	P25788
GSVRGGDEIFLLCDK	REL	196	Q04864
HRDFAGELEVLCKLG	TEK	866	Q02763
IDGEVGLFLLGCVKE	TRIM51G	371	A0A3B3IT33
CREVGKDFLAKLGFL	ZNF154	91	Q13106
CEQRLKDLGVLGSFI	VPS33A	121	Q96AX1
KGLCLKYLGRVQEAE	TTC39A	511	Q5SRH9
GLLDLVKARACGDLR	TRIM56	81	Q9BRZ2
RKGDEFVLKEGQLLC	LMX1B	151	O60663
SLRDEGVKFLCEALG	NLRP13	906	Q86W25
KVFCELLGLESGRVA	MYO5C	356	Q9NQX4